Endo Pharmaceuticals, the marketer of pain medications, has reached an agreement to acquire Indevus Pharmaceuticals in a deal that is intended to bolster its pipeline and expand its business beyond pain therapy. Indevus specialises in urology and endocrinology and has two products awaiting approval.